EMBLA MEDICAL HF (OSSUY) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 5 12 sessions, November 3, 2025 to July 24, 2026
- Largest daily move
- -14% close of March 13, 2026
- 5-year change
- +248.7% closing prices, July 23, 2021 to July 24, 2026
Company Description
EMBLA MEDICAL HF (OTC: OSSUY) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $2.2B.
OSSUY has declined 22.9% so far this year. The last closing price was $4.15.
This page collects what Stock Titan holds for OSSUY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
EMBLA MEDICAL HF (OSSUY) closed at $4.15 on July 24, 2026. So far this year, the price has lost 22.9%.
OSSUY Metrics & Rankings
Price returns through July 24, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in EMBLA MEDICAL HF (OSSUY) currently stands at 237 shares, representing 0.0% of the shares outstanding. Since September 2025, short interest has increased by 264.6%. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for EMBLA MEDICAL HF (OSSUY) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
OSSUY Company Profile & Sector Positioning
EMBLA MEDICAL HF (OSSUY) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing OSSUY often look at related companies in the same sector, including VITROLIFE AB (VTRLY), GN STORE NORD A/S (GNNDY), GETINGE AB (GNGBY), DRAEGERWERK AG (DGWPF), and KUROS BIOSCIENCE (CSBTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OSSUY's relative position within its industry.